The market for single-use bioreactors is growing at an annualized rate of over 18%, claims Roots Analysis



Traditionally, stainless steel bioreactors were the preferred choice for production of biologics; however, over the past couple of decades

Press Release

Single-use bioreactors are a revolutionary product of the process optimization efforts of drug manufacturers, offering a highly flexible approach to rapidly produce multiple drugs, while notably reducing downtime between batches and operational costs


Roots Analysis has announced the addition of “Single-Use Bioreactors Market, 2021-2030” report to its list of offerings.


Traditionally, stainless steel bioreactors were the preferred choice for production of biologics; however, over the past couple of decades, biopharmaceutical manufacturing has gradually witnessed a shift towards the use of single-use technologies. Apart from low contamination risk and better product yield, single-use bioreactors are easy-to-install and have a much smaller footprint, compared to the traditional stainless steel systems.


To order this 267 page report, which features 110 figures and 160 tables, please visit –


Key Market Insights


160 single-use bioreactors are currently available / under development for different scales of operation

It is worth noting that most of the single-use bioreactors (49%) are stirred tank bioreactors, followed by pneumatically mixed bioreactors (9%). It is worth highlighting that nearly 70% of single-use bioreactors support laboratory scale operations.


Majority (40%) of the single-use bioreactors are intended for mammalian cell culture

Presently, several bioreactors are also being used to culture appropriate host cells for studying the pathogenesis of the novel coronavirus. Other popular application areas for single-use bioreactors include stem cell research (47%), and cancer research (20%).


Close to 40 players are driving the activity within the single-use bioreactors industry

Majority (47%) of the initiatives in this domain are led by small-sized firms, followed by mid-sized (24%) and large players (29%). Further, around 60% of the firms engaged in providing single-use bioreactors were established post 2000.


To request a sample copy / brochure of this report, please visit this –


The USD 6.6 billion (by 2030) financial opportunity within the single-use bioreactors market has been analyzed across the following segments:


  • Type of Cell Culture
  • Bacterial Cell Cultures
  • Insect Cell Cultures
  • Mammalian Cell Cultures
  • Microbial Cell Cultures
  • Plant Cell Cultures
  • Viral Cell Cultures
  • Other Cell Cultures


  • Type of Molecule
  • Cell Therapies
  • Gene Therapies
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Stem Cell Therapies
  • Vaccines
  • Other Molecules

For additional details, please visit




Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Facebook –

LinkedIn –

Twitter –